ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JONATHAN FLACKER M.D.

EMMA I DARNELL GERIATRICS CENTER 80 JESSE HILL JR DRIVE

Atlanta | Georgia | 30303

(404) 616-7642

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,107Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 36

$516K Total Retail Price of All Prescriptions

Rank: 16 out of 36

446 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 446 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 446 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 9,067 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 481 481 1 2
AMLODIPINE BESYLATE 407 407 2 1
LISINOPRIL 338 338 3 3
LEVOTHYROXINE SODIUM 299 299 4 4
DONEPEZIL HCL 278 277 5 12
CITALOPRAM HBR 262 262 6 16
FUROSEMIDE 220 220 7 5
OMEPRAZOLE 210 210 8 6
HYDROCHLOROTHIAZIDE 196 195 9 9
METOPROLOL TARTRATE 185 185 10 8
NAMENDA 168 167 11 13
LOSARTAN POTASSIUM 160 160 12 23
METOPROLOL SUCCINATE 159 159 13 18
MIRTAZAPINE 158 158 14 28
SERTRALINE HCL 133 133 15 19
QUETIAPINE FUMARATE 128 126 16 37
DIOVAN 122 116 17 40
KLOR-CON M20 114 114 18 32
TAMSULOSIN HCL 113 113 19 41
TRAMADOL HCL 110 110 20 14
ATORVASTATIN CALCIUM 106 102 21 22
NIFEDIPINE ER 106 106 21 104
RISPERIDONE 102 102 23 31
NEXIUM 98 98 24 26
CYMBALTA 91 91 25 48
TRAZODONE HCL 84 84 26 39
ATENOLOL 83 83 27 27
METFORMIN HCL 79 79 28 11
CARVEDILOL 78 78 29 20
FLUTICASONE PROPIONATE 78 78 29 45
HYDROCODONE-ACETAMINOPHEN 74 74 S3 31 7
CARBIDOPA-LEVODOPA 73 73 32 73
ALENDRONATE SODIUM 73 73 32 34
GABAPENTIN 72 72 34 10
PRAVASTATIN SODIUM 72 72 34 21
FAMOTIDINE 70 70 36 30
FINASTERIDE 68 68 37 108
RANITIDINE HCL 68 68 37 25
ZOLPIDEM TARTRATE 66 66 39 24
POLYETHYLENE GLYCOL 3350 63 63 40 43
CLOPIDOGREL 57 57 41 33
SPIRIVA 56 56 42 76
ADVAIR DISKUS 54 54 43 70
PANTOPRAZOLE SODIUM 52 52 44 35
POTASSIUM CHLORIDE 50 50 45 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.